Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK) (N-Term) Peptide
HRK
适用: 人
宿主: 合成
BP, WB
Quick Overview for Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK) (N-Term) Peptide (ABIN978244)
抗原
HRK
(Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK))
宿主
人
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB)
-
-
蛋白结构域
- N-Term
-
产品特性
- This is a synthetic peptide designed for use in combination with anti-HRK antibody (Catalog #: ARP46364_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
纯化方法
- Purified
-
-
-
-
应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
浓度
- 1 mg/mL
-
缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HRK (Harakiri, BCL2 Interacting Protein (Contains Only BH3 Domain) (HRK))
-
背景
-
Activator of apoptosis Hrk regulates apoptosis through interaction with death-repressor proteins Bcl-2 and Bcl-X(L). The HRK protein lacks significant homology to other BCL2 family members except for an 8-amino acid region that was similar to the BCL2 hom
Alias Symbols: DP5, HARAKIRI
Protein Interaction Partner: BCL2,BCL2,BCL2A1,BCL2L1,BCL2L1,BCL2L1,BCL2L2,BNC1,BAD,BCL2,BCL2A1,BCL2L1,BCL2L2,C1QBP,BCL2,BCL2A1,BCL2L1,BCL2L2,MCL1
Protein Size: 91 -
分子量
- 10 kDa
-
基因ID
- 8739
-
NCBI登录号
- NM_003806, NP_003797
-
UniProt
- O00198
抗原
-
You are here:
